These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18803458)

  • 1. Could rusalatide acetate be the future drug of choice for diabetic foot ulcers and fracture repair?
    Carney DH; Olszewska-Pazdrak B
    Expert Opin Pharmacother; 2008 Oct; 9(15):2717-26. PubMed ID: 18803458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombin peptide TP508 stimulates cellular events leading to angiogenesis, revascularization, and repair of dermal and musculoskeletal tissues.
    Ryaby JT; Sheller MR; Levine BP; Bramlet DG; Ladd AL; Carney DH
    J Bone Joint Surg Am; 2006 Nov; 88 Suppl 3():132-9. PubMed ID: 17079379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technology evaluation: Chrysalin (Orthologic).
    Rodgers KE
    Curr Opin Mol Ther; 2005 Jun; 7(3):264-72. PubMed ID: 15977425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin peptide Chrysalin stimulates healing of diabetic foot ulcers in a placebo-controlled phase I/II study.
    Fife C; Mader JT; Stone J; Brill L; Satterfield K; Norfleet A; Zwernemann A; Ryaby JT; Carney DH
    Wound Repair Regen; 2007; 15(1):23-34. PubMed ID: 17244316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration.
    O'Meara S; Cullum N; Majid M; Sheldon T
    Health Technol Assess; 2000; 4(21):1-237. PubMed ID: 11074391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
    Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
    Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers.
    Curran MP; Plosker GL
    BioDrugs; 2002; 16(6):439-55. PubMed ID: 12463767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrogel dressings for healing diabetic foot ulcers.
    Dumville JC; O'Meara S; Deshpande S; Speak K
    Cochrane Database Syst Rev; 2011 Sep; (9):CD009101. PubMed ID: 21901730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Connexin 43-Based Therapeutics for Dermal Wound Healing.
    Montgomery J; Ghatnekar GS; Grek CL; Moyer KE; Gourdie RG
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29914066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Polymer coatings with immobilized thrombin and peptides: preparation and use for wound healing].
    Markvicheva EA; Kuptsova SV; Rumsh LD; Dugina TN; Lange MA; Chistov IV; Strukova SM; Zubov VP
    Vopr Med Khim; 2002; 48(6):570-6. PubMed ID: 12698556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human epidermal growth factor (REGEN-D 150): effect on healing of diabetic foot ulcers.
    Mohan VK
    Diabetes Res Clin Pract; 2007 Dec; 78(3):405-11. PubMed ID: 17655964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silver based wound dressings and topical agents for treating diabetic foot ulcers.
    Bergin SM; Wraight P
    Cochrane Database Syst Rev; 2006 Jan; (1):CD005082. PubMed ID: 16437516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tactics of modern-day regulatory trials.
    Dent-Acosta RE; Storm N; Steiner RS; San Martin J
    J Bone Joint Surg Am; 2012 Jul; 94 Suppl 1():39-44. PubMed ID: 22810446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin peptide (TP508) promotes fracture repair by up-regulating inflammatory mediators, early growth factors, and increasing angiogenesis.
    Wang H; Li X; Tomin E; Doty SB; Lane JM; Carney DH; Ryaby JT
    J Orthop Res; 2005 May; 23(3):671-9. PubMed ID: 15885490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TP508 accelerates fracture repair by promoting cell growth over cell death.
    Li X; Wang H; Touma E; Qi Y; Rousseau E; Quigg RJ; Ryaby JT
    Biochem Biophys Res Commun; 2007 Dec; 364(1):187-93. PubMed ID: 17942078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated healing of diabetic wounds by NorLeu(3)-angiotensin (1-7).
    Rodgers K; Verco S; Bolton L; Dizerega G
    Expert Opin Investig Drugs; 2011 Nov; 20(11):1575-81. PubMed ID: 21973177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Talactoferrin alfa, a recombinant human lactoferrin promotes healing of diabetic neuropathic ulcers: a phase 1/2 clinical study.
    Lyons TE; Miller MS; Serena T; Sheehan P; Lavery L; Kirsner RS; Armstrong DG; Reese A; Yankee EW; Veves A
    Am J Surg; 2007 Jan; 193(1):49-54. PubMed ID: 17188087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial report of the use of an injectable porcine collagen-derived matrix to stimulate healing of diabetic foot wounds in humans.
    Marston WA; Usala A; Hill RS; Mendes R; Minsley MA
    Wound Repair Regen; 2005; 13(3):243-7. PubMed ID: 15953042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of diabetic wound healing by topical application of Vicenin-2 hydrocolloid film on Sprague Dawley rats.
    Tan WS; Arulselvan P; Ng SF; Mat Taib CN; Sarian MN; Fakurazi S
    BMC Complement Altern Med; 2019 Jan; 19(1):20. PubMed ID: 30654793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with topical nitroglycerine may promote the healing process of diabetic foot ulcers.
    Mikaili P; Moloudizargari M; Aghajanshakeri S
    Med Hypotheses; 2014 Aug; 83(2):172-4. PubMed ID: 24880867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.